Viokace shortage expected from Feb 2027 to Nov 2027 due to ingredient delays
Official source: Health Product Shortages Canada (opens in a new tab)
Healthcare news
News for New Brunswick’s health workforce
Short briefs on what is changing in healthcare in New Brunswick and across Canada, collected from official bodies and news outlets, each linked to its original source.
Check the original source before acting.
AbbVie to stop production of 40 mg Humira pens and syringes
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex saxagliptin 2.5 mg shortage lasts until Jan 8
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports manufacturing disruption causing shortage of 10 mg rupatadine tablets
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex duloxetine 60 mg shortage continues through Nov 20
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex levetiracetam 500 mg shortage lasts until Dec 4 due to manufacturing disruption
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports manufacturing disruption causing shortage of 300 mg gabapentin capsules
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports manufacturing disruption causing shortage of 4 mg ondansetron tablets
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports manufacturing disruption causing shortage of 40 mg citalopram tablets
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports manufacturing disruption causing shortage of 8 mg ondansetron tablets
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports manufacturing disruption causing shortage of fluoxetine 20 mg oral solution
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports manufacturing disruption causing shortage of sitagliptin and metformin tablets
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports manufacturing disruption causing 2.5 mg ramipril capsule shortage
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports manufacturing disruption causing shortage of 80 mg oxycodone tablets
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports manufacturing disruption causing shortage of 150 mg oxcarbazepine tablets
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports manufacturing disruption causing shortage of 5 mg methylphenidate tablets
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports 50 mg hydrochlorothiazide tablet shortage until November 6
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports manufacturing disruption causing shortage of 100 mg gabapentin capsules
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports manufacturing disruption causing shortage of 400 mg gabapentin capsules
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports manufacturing disruption causing shortage of 30 mg duloxetine capsules
Official source: Health Product Shortages Canada (opens in a new tab)
Apotex reports manufacturing disruption causing shortage of 40 mg doxycycline capsules
Official source: Health Product Shortages Canada (opens in a new tab)
AA Pharma reports manufacturing disruption causing shortage of 100 mg minocycline capsules
Official source: Health Product Shortages Canada (opens in a new tab)
AA Pharma reports manufacturing disruption causing shortage of 10 mg diazepam tablets
Official source: Health Product Shortages Canada (opens in a new tab)
AA Pharma reports shortage of 125 mg methyldopa tablets until November 13
Official source: Health Product Shortages Canada (opens in a new tab)
AA Pharma reports manufacturing disruption causing 30 mg temazepam capsule shortage
Official source: Health Product Shortages Canada (opens in a new tab)
AA Pharma reports Ipravent nasal spray shortage lasting until November 6
Official source: Health Product Shortages Canada (opens in a new tab)
AA Pharma reports manufacturing disruption causing brimonidine eye drop shortage until November
Official source: Health Product Shortages Canada (opens in a new tab)
AA Pharma reports manufacturing disruption causing shortage of 10 mg nortriptyline capsules
Official source: Health Product Shortages Canada (opens in a new tab)
Governance requirements remain for digital health tools built using AI
News source: Digital Health Canada (opens in a new tab)
Teva reports manufacturing disruption causing shortage of 5 mg oxycodone tablets
Official source: Health Product Shortages Canada (opens in a new tab)